RSCM
MRSN icon

Rock Springs Capital Management’s Mersana Therapeutics MRSN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.13M Hold
3,814,684
0.07% 84
2025
Q1
$1.31M Buy
3,814,684
+383,000
+11% +$132K 0.08% 84
2024
Q4
$4.91M Buy
3,431,684
+384,902
+13% +$550K 0.19% 79
2024
Q3
$5.76M Hold
3,046,782
0.19% 81
2024
Q2
$6.12M Hold
3,046,782
0.18% 78
2024
Q1
$13.6M Hold
3,046,782
0.35% 68
2023
Q4
$7.07M Sell
3,046,782
-356,351
-10% -$827K 0.17% 78
2023
Q3
$4.32M Hold
3,403,133
0.12% 86
2023
Q2
$11.2M Sell
3,403,133
-700,670
-17% -$2.31M 0.27% 74
2023
Q1
$16.9M Hold
4,103,803
0.4% 64
2022
Q4
$24M Buy
4,103,803
+27,845
+0.7% +$163K 0.58% 51
2022
Q3
$27.6M Hold
4,075,958
0.71% 46
2022
Q2
$18.8M Buy
4,075,958
+320,138
+9% +$1.48M 0.55% 53
2022
Q1
$15M Buy
3,755,820
+506,870
+16% +$2.02M 0.38% 67
2021
Q4
$20.2M Buy
3,248,950
+228,248
+8% +$1.42M 0.47% 64
2021
Q3
$28.5M Buy
3,020,702
+175,084
+6% +$1.65M 0.6% 55
2021
Q2
$38.6M Buy
2,845,618
+70,491
+3% +$957K 0.76% 48
2021
Q1
$44.9M Buy
2,775,127
+711,460
+34% +$11.5M 0.98% 31
2020
Q4
$54.9M Buy
2,063,667
+178,239
+9% +$4.74M 1.16% 27
2020
Q3
$35.1M Buy
1,885,428
+7,000
+0.4% +$130K 0.89% 37
2020
Q2
$44M Buy
1,878,428
+645,428
+52% +$15.1M 1.21% 27
2020
Q1
$7.19M Hold
1,233,000
0.3% 87
2019
Q4
$7.07M Sell
1,233,000
-167,000
-12% -$957K 0.22% 96
2019
Q3
$2.21M Hold
1,400,000
0.09% 125
2019
Q2
$5.67M Hold
1,400,000
0.21% 95
2019
Q1
$7.36M Buy
1,400,000
+400,000
+40% +$2.1M 0.28% 92
2018
Q4
$4.08M Hold
1,000,000
0.19% 105
2018
Q3
$10M Hold
1,000,000
0.36% 86
2018
Q2
$17.9M Sell
1,000,000
-300,000
-23% -$5.36M 0.69% 48
2018
Q1
$20.5M Sell
1,300,000
-26,800
-2% -$423K 0.87% 38
2017
Q4
$21.8M Sell
1,326,800
-3,200
-0.2% -$52.6K 0.99% 31
2017
Q3
$23M Sell
1,330,000
-197,893
-13% -$3.42M 1.06% 27
2017
Q2
$21.3M Buy
+1,527,893
New +$21.3M 1.08% 31